Chargement en cours...
Type I Interferons: Beneficial in Th1 and Detrimental in Th17 Autoimmunity
In relapsing remitting multiple sclerosis (RRMS), type I interferon (IFN) is considered immuno-modulatory and recombinant forms of IFN-β are the most prescribed treatment for this disease. However, within the RRMS population, 30–50% of MS patients are nonresponsive to this treatment, and it consiste...
Enregistré dans:
| Publié dans: | Clin Rev Allergy Immunol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5478162/ https://ncbi.nlm.nih.gov/pubmed/22231516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12016-011-8296-5 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|